Form 4 for LGND LIGAND PHARMACEUTICALS INC
Accepted 2026-02-18 00:00:00 ET · period of report 2026-02-14 · accession 0002001011-26-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-02-18 | 2026-02-14+ | LGND | Davis Todd C | CEO, Dir | F - Tax | $183.83 | -32.9K | 198.0K | -14% | -$6.04M |
| M | 2026-02-18 | 2026-02-14 | LGND | Davis Todd C | CEO, Dir | A - Grant | $0.00 | +60.4K | 182.1K | +50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-15 | F | D | 2,039 | $183.83 | 195,946 | D | — | — | (F3) Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units. |
| 2 | Common | Common Stock | 2026-02-15 | F | D | 4,255 | $183.83 | 191,691 | D | — | — | (F3) Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units. |
| 3 | Common | Common Stock | 2026-02-15 | F | D | 2,805 | $183.83 | 188,886 | D | — | — | (F3) Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units. |
| 4 | Common | Common Stock | 2026-02-14 | A | A | 39,644 | $0.00 | 213,585 | D | — | — | (F1) Represents shares of common stock issued upon the vesting and certification of performance stock units ("PSUs"). |
| 5 | Common | Common Stock | 2026-02-14 | F | D | 8,178 | $183.83 | 173,941 | D | — | — | (F2) Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of PSUs. |
| 6 | Common | Common Stock | 2026-02-14 | A | A | 20,782 | $0.00 | 182,119 | D | — | — | (F1) Represents shares of common stock issued upon the vesting and certification of performance stock units ("PSUs"). |
| 7 | Common | Common Stock | 2026-02-14 | F | D | 15,600 | $183.83 | 197,985 | D | — | — | (F2) Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of PSUs. |